Clinical trial Recruiting at 1 site Observational Ages 19 and up Women only

Identifying stillbirth risk using ultrasound

Official title: Stillbirth Risk Identification Using Multiparametric Ultrasound

Run by University of British Columbia · NCT06930274 · Data updated 2026-11-12

This study is testing a new way to use ultrasound to see if it can help identify risks for stillbirth by checking the placenta in pregnant women between 35 and 37 weeks.

Quick facts

Study typeObservational
Ages19 Years and up
SexWomen only
Enrollment282 (estimated)
SponsorUniversity of British Columbia
Academic / other
Locations1 site (Vancouver, British Columbia)
StatusRecruiting
StartedJanuary 3, 2023
Main results expectedJuly 30, 2025
Study endsSeptember 30, 2025
Registry record updatedApril 16, 2025
Trial IDNCT06930274 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant individuals aged 19 years or older, carrying a singleton fetus, and planning to deliver at BC Women's Hospital before 38 weeks of gestation.

Probably not a fit

Patients who are pregnant with multiples or those who are not planning to deliver at BC Women's Hospital will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify a novel biomarker for stillbirth by predicting perinatal hypoxia through quantitative ultrasound of the placenta between 35 and 37 weeks of gestation. The study collects raw radio frequency data during ultrasounds using a handheld device and analyzes it to derive QUS-P parameters. The goal is to enable early identification of perinatal hypoxia, allowing for timely interventions to prevent serious complications such as encephalopathy and stillbirth.

Why it matters

Potential benefit: If successful, this study could significantly reduce the incidence of stillbirth by enabling earlier detection and intervention for at-risk pregnancies.

How similar studies have gone: Other studies have shown promise in using ultrasound for similar predictive purposes, but this specific approach using quantitative ultrasound from the placenta is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Pregnant with singleton
2. Age 19 years or older
3. Provision of informed consent
4. Planning to deliver at BC Women's Hospital
5. 38 weeks gestation or less

Exclusion Criteria:

1. Pregnant with multiples
2. Not planning to deliver at BC Women's Hospital
3. Less than 19 years of age
4. Greater than 38 weeks gestation

Where it's running

  • South Community Birth Program
    Vancouver, British Columbia, Canada
    Recruiting

Study contacts

  • Principal investigator: Robert Rohling, PhD — The University of British Columbia
  • Study coordinator: Tiffany Reeve, MSc
  • Email: treeve@mail.ubc.ca
  • Phone: 778-227-1243

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.